Insmed
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $142,342 | $107,415 | $92,823 | $104,442 |
Gross Profit | 83,612 | 79,340 | 71,545 | 78,291 |
EBITDA | -344,323 | -297,127 | -232,778 | -211,739 |
EBIT | -348,319 | -300,874 | -235,924 | -214,480 |
Net Income | -370,021 | -321,686 | -256,583 | -235,548 |
Net Change In Cash | 142,342 | 107,415 | 92,823 | 104,442 |
Free Cash Flow | -222,179 | -209,053 | -272,158 | -202,751 |
Cash | 334,764 | 1,284,324 | 403,247 | 555,030 |
Basic Shares | 211,441 | 189,302 | 180,860 | 179,021 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $363,707 | $305,208 | $245,358 | $188,461 |
Gross Profit | 277,965 | 239,635 | 190,232 | 144,309 |
EBITDA | -818,794 | -660,177 | -447,365 | -383,647 |
EBIT | -829,807 | -670,756 | -457,696 | -397,829 |
Net Income | -913,772 | -749,567 | -481,534 | -434,654 |
Net Change In Cash | 363,707 | 305,208 | 245,358 | 188,461 |
Cost of Revenue | 358,250 | 184,959 | ||
Free Cash Flow | -705,805 | -549,535 | -410,317 | -370,591 |
Cash | 555,030 | 482,374 | 1,074,036 | 716,782 |
Basic Shares | 164,043 | 140,433 | 123,035 | 112,111 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$1.75 |
2025-06-30 | -$1.70 |
2025-03-31 | -$1.42 |
